Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of Pioglitazone, Metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study
Hanefeld, Markolf, Pfützner, Andreas, Forst, Thomas, Kleine, Iris, Fuchs, WinfriedVolume:
10
Langue:
english
Journal:
Cardiovascular Diabetology
DOI:
10.1186/1475-2840-10-65
Date:
December, 2011
Fichier:
PDF, 321 KB
english, 2011